Toggle navigation
Home
Search
Services
Blog
Contact
About
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne
Intraimmune Therapies, Inc., Boston, MA, United States
Search 27 grants from Anne Messer
Search grants from Intraimmune Therapies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
De Novo Assembly Tools: Research with Unbiased Engines (DNA-TRUE)
Biobehavioral Pain Management in TMD
NCI, Division of Cancer Prevention Protocol Information Office Support
Early Innate Immune Response in Dengue Virus Infection
Pathogenesis of HIV Induced Immunodeficiency
Recently added grants:
Bright light modulation of non-motor symptoms in Parkinson's disease
Tissue Engineered Human Neuromuscular Junctions for Modeling Axonal Neuropathy
Role of fibrinogen in Alzheimer's disease
The role of inhibitory microcircuits in the neural control of breathing
Network Properties of Circadian Clock Modulation and Entrainment
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42NS038002-02
Application #
6073705
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Oliver, Eugene J
Project Start
1998-08-01
Project End
2002-01-31
Budget Start
2000-02-15
Budget End
2001-01-31
Support Year
2
Fiscal Year
2000
Total Cost
$250,000
Indirect Cost
Institution
Name
Intraimmune Therapies, Inc.
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02114
Related projects
NIH 2001
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Abgenix, Inc.
$250,000
NIH 2000
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Intraimmune Therapies, Inc.
$250,000
Comments
Be the first to comment on Anne Messer's grant